Heather Kiessling
Financieel Directeur/CFO bij ASP ISOTOPES INC.
Vermogen: 2 M $ op 31-05-2024
Oorsprong van het eerstegraads netwerk van Heather Kiessling
| Entiteit | Type entiteit | Industrie | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 7 | |
American Type Culture Collection
 American Type Culture Collection BiotechnologyHealth Technology American Type Culture Collection operates as a global biological materials resource and standards organization offering a collection of products and services. Its services include production and characterization, testing, biorepository, and deposit. The company was founded in 1925 and is headquartered in Manassas, VA.
4
| Non-Profit Organization | Biotechnology | 4 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Heather Kiessling via zijn persoonlijke netwerk
| Onderneming | Sector | Gelieerde personen | Hoofdpost |
|---|---|---|---|
Morgan Stanley & Co. International Plc
 Morgan Stanley & Co. International Plc Investment Banks/BrokersFinance Morgan Stanley & Co. International Plc (MSCI) is a brokerage firm headquartered in London, UK. The firm was founded in 1986 and is a subsidiary of Morgan Stanley Investments (UK), ultimately held by Morgan Stanley (NYSE: MS) in the US. MSCI provides a range of brokerage services to corporations, governments and financial institutions. | Investment Banks/Brokers | Analyst-Equity Analyst-Equity | |
| ABEONA THERAPEUTICS INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Varian Biopharmaceuticals, Inc.
 Varian Biopharmaceuticals, Inc. BiotechnologyHealth Technology Part of Healthtech Solutions, Inc., Varian Biopharmaceuticals, Inc. is a private precision oncology company based in Naples, FL. Varian Bio is developing novel therapeutics for the treatment of cancer using precision oncology, which involves DNA testing to identify genetic mutations in tumors for more targeted treatment recommendations. Varian Bio's lead drug candidate, Var-101, is being developed in a topical formulation for the treatment of basal cell carcinoma, while Var-102, an oral formulation, is being developed for the treatment of various solid tumors, including non-small cell lung cancer, pancreatic cancer, and colorectal cancer. Varian Bio is also seeking additional precision oncology therapeutic candidates for its pipeline and exploring development collaborations. The CEO of the company is Jeffrey Blaine Davis. Varian Biopharmaceuticals was acquired by Healthtech Solutions, Inc. on May 07, 2021. | Biotechnology | Chairman Director/Board Member | |
| University of Cambridge | College/University | Doctorate Degree Graduate Degree | |
Emendo Biotherapeutics, Inc.
 Emendo Biotherapeutics, Inc. BiotechnologyHealth Technology Emendo Biotherapeutics, Inc. engages in the development of genome editing technology. It specializes in protein engineering, molecular biology, and gene editing systems. The company was founded by David Baram, Lior Izhar, and Rachel Diamant in 2015 and is headquartered in New York, NY. | Biotechnology | Chairman | |
| ARYA SCIENCES ACQUISITION CORP IV | Financial Conglomerates | Director/Board Member | |
| Wider Film Projects | Corporate Officer/Principal | ||
| Columbia University College of Physicians & Surgeons | College/University | Doctorate Degree | |
| Princeton University | College/University | Undergraduate Degree | |
| Xanadu Bio Inc. | Founder | ||
| HEALTHTECH SOLUTIONS INC. | Packaged Software | Chairman | |
Highbridge Capital Management LLC
 Highbridge Capital Management LLC Investment ManagersFinance Highbridge Capital Management LLC (HCM Highbridge is a registered investment advisor and global alternative investment firm headquartered in New York City. The firm was founded in 1992 and is a subsidiary of JPMorgan Asset Management Holdings Inc., which is a wholly-owned subsidiary of JPMorgan Chase & Co. (NYSE: JPM). Highbridge manages capital for sophisticated investors, who include financial institutions, public and corporate pension funds, sovereign wealth funds, endowments and family offices. | Investment Managers | Corporate Officer/Principal | |
| ARYA SCIENCES ACQUISITION CORP V | Financial Conglomerates | Director/Board Member | |
| LANNETT COMPANY, INC. | Pharmaceuticals: Major | Director/Board Member | |
| GENENTA SCIENCE S.P.A. | Pharmaceuticals: Major | Director/Board Member | |
| Nelson Mandela Metropolitan University | College/University | Graduate Degree | |
| University of Oxford | College/University | Doctorate Degree | |
| Bear Stearns & Co. Ltd. | Corporate Officer/Principal | ||
BlueZest Mortgages & Loans Ltd.
 BlueZest Mortgages & Loans Ltd. Finance/Rental/LeasingFinance Part of Unique Funding Ltd., BlueZest Mortgages & Loans Ltd. is a British company that offers an online platform for home and business secured finance. The company is based in London, UK. The company was founded by Robert Ainscow. | Finance/Rental/Leasing | Founder | |
| Zenzic Partners Ltd. | Corporate Officer/Principal | ||
| University of the West of England | College/University | Undergraduate Degree | |
| University of KwaZulu-Natal | College/University | Doctorate Degree | |
| University of Pretoria | College/University | Undergraduate Degree | |
SFM UK Management LLP
 SFM UK Management LLP Investment ManagersFinance SFM UK Management LLP (SFM UK) is the Great Britain-based alternative investment subsidiary of Soros Fund Management LLC in the US. Headquartered in London, SFM UK was founded in 2008 and manages assets of high net worth clients. | Investment Managers | Analyst-Equity | |
| Klydon Pty Ltd. | Chief Executive Officer | ||
| South African Atomic Energy Corp. | Chief Tech/Sci/R&D Officer | ||
| ARBUTUS BIOPHARMA CORPORATION | Pharmaceuticals: Major | Director/Board Member | |
| Mvr Consulting, Inc. | Founder | ||
| INTERCEPT PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| Rice University | College/University | Doctorate Degree | |
UBS AG (Private Banking UK)
 UBS AG (Private Banking UK) Investment ManagersFinance UBS AG (Private Banking UK) is the Great Britain-based private banking division of UBS AG (London Branch), ultimately held by UBS Group AG (NYSE: UBS, SWX: UBSG) in Switzerland. Headquartered in London, the firm was founded 1998 and provides a range of private banking services to high-net worth clients. | Investment Managers | Analyst-Equity | |
Deutsche Bank AG (Broker UK)
 Deutsche Bank AG (Broker UK) Investment Banks/BrokersFinance Deutsche Bank AG (Deutsche Bank UK) is the UK-based securities brokerage division of Deutsche Bank AG (ETR: DBK) in Germany. The firm is headquartered in London and was founded in 1873. Deutsche Bank provides brokerage services to companies and institutions. | Investment Banks/Brokers | Analyst-Equity | |
| FORWARD PHARMA A/S | Pharmaceuticals: Major | Director/Board Member | |
| ALLARITY THERAPEUTICS, INC. | Pharmaceuticals: Major | Chairman | |
| Ultraclone Ltd. | Founder | ||
Scottish Lifesciences Association
 Scottish Lifesciences Association Miscellaneous Commercial ServicesCommercial Services The Scottish Lifesciences Association operates an association for life sciences companies and organizations. | Miscellaneous Commercial Services | Chairman | |
Merchiston Castle School
 Merchiston Castle School Other Consumer ServicesConsumer Services Merchiston Castle School is a non-profit organization, which operates a boarding and day school for boys. It offers education for Juniors, Middle Years, and Sixth Form. The company is headquartered in Edinburgh, the United Kingdom. | College/University | Director/Board Member | |
Allarity Therapeutics A/S
 Allarity Therapeutics A/S Pharmaceuticals: MajorHealth Technology Allarity Therapeutics A/S is a biotechnology company, which engages in the research and development of anti-cancer drugs. Its product pipeline includes LiPlaCis, 2X-121, 2X-111, irofulven phase 2, and APO010.The company was founded by Steen Meier Knudsen and Peter Buhl Jensen in 2004 and is headquartered in Hoersholm, Denmark. | Pharmaceuticals: Major | Chairman | |
Cycle Pharmaceuticals Ltd.
 Cycle Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Cycle Pharmaceuticals Ltd. is a privately-owned biotechnology company headquartered in Cambridge, UK. The British company focuses on rare metabolic, immunological, and neurological genetic conditions, including multiple sclerosis. Cycle Pharmaceuticals utilizes the latest pharmaceutical technologies to provide superior drug treatments and individualized patient support services. Cycle Pharmaceuticals Ltd. was founded in 2012 with the aim of delivering drug treatments and services to the under-served rare disease patient community. James Alexander Harrison has been the CEO of the company since 2012. | Pharmaceuticals: Major | Director/Board Member | |
Braidlock Ltd.
 Braidlock Ltd. Medical SpecialtiesHealth Technology Braidlock Ltd. engages in the development and manufacture of medical products. Its products include Braidlock Chevron and Braidlock NG. The company was founded in 2004 and is headquartered in Prestwick, the United Kingdom. | Medical Specialties | Corporate Officer/Principal | |
International School of Beijing
 International School of Beijing Miscellaneous Commercial ServicesCommercial Services International School of Beijing engages in the education services. It runs, operates and manages educational institution and international school. The company was founded in 1980 and is headquartered in Beijing, China. | Miscellaneous Commercial Services | Corporate Officer/Principal |
Statistieken
Internationaal
| Verenigde Staten | 24 |
| Verenigd Koninkrijk | 18 |
| Zuid-Afrika | 6 |
| Denemarken | 3 |
| Italië | 2 |
Sectoraal
| Health Technology | 14 |
| Finance | 13 |
| Consumer Services | 12 |
| Technology Services | 3 |
| Commercial Services | 3 |
Operationeel
| Director/Board Member | 31 |
| Independent Dir/Board Member | 16 |
| Chairman | 15 |
| Corporate Officer/Principal | 11 |
| Analyst-Equity | 9 |
Sterkste connecties
| Insiders | |
|---|---|
| Duncan Moore | 19 |
| Paul Mann | 17 |
| Todd Wider | 15 |
| Steven Curts | 13 |
| Melissa Rewolinski | 7 |
| Hendrik Strydom | 6 |
| Robert Ainscow | 5 |
| Raymond H. Cypess | 3 |
| Mike Gorley | 2 |
| Rob Ryan | 2 |
| Nancy J. Wysocki | 1 |
- Beurs
- Insiders
- Heather Kiessling
- Bedrijfsconnecties
